Mechanism-Based Inactivation of Ribonuclease A.
Jeffrey K Stowell1, Theodore S Widlanski1, Tatiana G Kutateladze2
1Department of Chemistry, Indiana University, Bloomington, Indiana 47405.
The Journal of Organic Chemistry
|April 3, 2025
Summary
Researchers report the first mechanism-based phosphodiesterase inhibitor. This study also introduces a novel, cost-effective method for synthesizing phosphate diesters, crucial for developing new enzyme inhibitors.
Area of Science:
- Biochemistry
- Organic Chemistry
- Medicinal Chemistry
Background:
- Mechanism-based inhibitors are crucial for targeted enzyme modulation.
- Developing novel inhibitors for phosphodiesterases and nucleases remains an active research area.
- Existing methods for synthesizing phosphate diesters can be limited.
Purpose of the Study:
- To report the first mechanism-based inhibitor of a phosphodiesterase.
- To present an efficient and inexpensive method for synthesizing phosphate diesters.
- To facilitate the development of new nucleases and phosphodiesterase inhibitors.
Main Methods:
- Synthesis of a novel fluoride-containing compound as a potential enzyme inhibitor.
- Development of a new phosphorylation strategy involving phosphitylation, iodination, and coupling reactions.
- Deprotection steps to yield the final phosphate diester products.
Main Results:
- Identification of fluoride 4 as a starting point for mechanism-based phosphodiesterase inhibitors.
- Successful synthesis of phosphate diesters not achievable through standard phosphoramidite methods.
- Demonstration of a versatile phosphorylation chemistry for complex molecule synthesis.
Conclusions:
- The reported inhibitor, though not fully inactivating, serves as a valuable lead compound.
- The novel synthetic route offers a cost-effective alternative for phosphate diester preparation.
- This work significantly advances the synthesis of mechanism-based enzyme inhibitors.
Related Concept Videos
Ribozymes
11.0K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
11.0K
Types of RNA
62.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
62.8K
Riboswitches
8.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
Nonsense-mediated mRNA Decay
10.4K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.4K


